Lack of pathogenic mutations in the 5′-untranslated region of the thrombopoietin gene in patients with non-familial essential thrombocythaemia

European Journal of Haematology

Volumn 67, Issue 4, 2001, Pages 232-237

  Allen, Anthony J R ^a   Gale, Rosemary E ^a   Harrison, Claire N ^a   Machin, Samuel J ^a   Linch, David C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

5 UTR; Essential thrombocythaemia; Polymorphism; Thrombopoietin

Indexed keywords

DNA; THROMBOPOIETIN;

5' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; EXON; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; THROMBOCYTHEMIA;

5' UNTRANSLATED REGIONS; ADOLESCENT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; CHILD; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE FREQUENCY; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN BIOSYNTHESIS; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOPOIETIN;

EID: 0035704766     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2001.00550.x     Document Type: Article

References (35)

1. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment
2. Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia
3. Clonality analysis of hematopoiesis in essential thrombocythemia: Advantages of studying T lymphocytes and platelets
4. A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications
5. Thrombopoietin
6. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo
7. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
8. Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells
9. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation
10. Murine thrombopoietin mRNA levels are modulated by platelet count
11. Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis
12. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets
13. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis
14. Thrombopoietin in thrombocytopenic mice: Evidence against regulation at the mRNA level and for a direct regulatory role of platelets
15. The reciprocal relationship of thrombopoietin (c-mpl ligand) to changes in the platelet mass during busulphan-induced thrombocytopenia in the rabbit
16. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction
17. Thrombopoietin levels in patients with primary and reactive thrombocytosis
18. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia
19. Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value
20. Thrombopoietin measurement in thrombocytosis: Dysregulation and lack of feedback inhibition in essential thrombocythaemia
21. Analysis of the thrombopoietin receptor (mpl) on platelets from normal and essential thrombocythemic (ET) patients
22. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera
23. Thrombopoietin production is inhibited by a translational mechanism
24. An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia
25. Familial essential thrombocythemia associated with one-base deletion in the 5′-untranslated region of the thrombopoietin gene
26. Hereditary thrombocythaemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene
27. Familial thrombocytosis associated with overproduction of thrombopoietin due to a novel splice donor site mutation
28. The activating splice mutation in intron 3 of the thrombopoietin gene is not found in patients with non-familial essential thrombocythaemia
29. A fast method for high-quality genomic DNA extraction from human whole blood
30. Cloning and characterization of the human megakaryocyte growth and development factor (MGDF) gene
31. A single-base deletion in the thrombopoietin (TPO) gene causes familial essential thrombocythemia through a mechanism of more efficient translation of TPO mRNA
32. Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin
33. Production of thrombopoietin by human carcinomas and its novel isoforms
34. Genes for thrombopoietin and c-mpl are not responsible for familial thrombocythaemia: A case study
35. Hereditary thrombocythaemia is a genetically heterogeneous disorder: Exclusion of TPO and MPL in two families with hereditary thrombocythaemia